Search Results for: prostate cancer

Prostate cancer screening: clear harms with uncertain benefits

Prostate cancer is the second most common cancer in men worldwide,14 and broadly falls into two types. Some men have […]

Overdiagnosing prostate cancer

Prostate cancer has been described as the par excellence example of overdiagnosis. This does not mean that there are not […]

Breast cancer screening: well established but remains contentious

Since routine breast screening with mammography is well established in many countries one could well assume that mammographic screening must […]

Why do we need fair tests of treatments?

Modern medicine has been hugely successful at reducing the impact of disease and increasing life expectancy. In spite of this, […]

More is less: an investigation of unnecessary testing

This is a US radio production about unnecessary testing and the associated harm to patients and costs to the health system.

Examples

These are stories about specific clinical cases, diseases or disease areas that illustrate the need for fair tests of treatments. […]

Design and conduct research properly

Stimulated by surveys revealing the poor quality of many reports of clinical trials, reporting standards have been developed and applied.  […]

3: Statistics are confusing – should patients really have to look at the numbers?

The way that numbers are presented can be very daunting – or even downright misleading. But if you really do […]

References (Section 4)

References for “Earlier is not necessarily better” 1 Raffle A, Gray M. Screening: evidence and practice. Oxford: Oxford University Press, […]

Working collaboratively bodes well for the future

There are numerous ways in which patients and the public can become involved in testing treatments. As we have already […]

Bridging the gap between patients and researchers

We drew attention above to problems that can result from patients becoming involved in testing treatments, and ways in which […]

Thumbnails

In TTi, Thumbnails are short stories that illustrate key points of the main text. We have grouped them into four […]

Discoverer of PSA speaks out

‘The test’s popularity has led to a hugely expensive public health disaster. It’s an issue I am painfully familiar with […]

Don’t assume early detection is worthwhile

‘Screening for neuroblastoma illustrates how easily one can fall into the trap of assuming that because a disease can be […]

Weighing benefits and harms

There are many examples of beneficial screening. Perhaps the most widely used in adults is the checking of risk factors […]

References (Section 13)

References for “Research for the right reasons: blueprint for a better future” 1 Chalmers 1, Glasziou P. Avoidable waste in […]